Background In the 5 years that have passed since the publication of the 2018 International
Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis …

Background Atopic dermatitis (AD, eczema) is driven by a combination of skin barrier
defects, immune dysregulation, and extrinsic stimuli such as allergens, irritants, and …

OBJECTIVES Describe clinical and epidemiologic patterns of pediatric allergy using
longitudinal electronic health records (EHRs) from a multistate consortium of US practices …

Allergic rhinitis in childhood has been often missed, mistreated and misunderstood. It has
significant comorbidities, adverse effects upon quality of life and educational performance …

Background Co‐medication is common among patients with allergic rhinitis (AR), but its
dimension and patterns are unknown. This is particularly relevant since AR is understood …

An updated edition of the International Consensus Statement on Allergy and Rhinology:
Allergic Rhinitis (ICAR: AR) has recently been published. This consensus document, which …

Background: We aim to assess the impact of montelukast on paediatric patients with
asthma/allergic rhinitis, measured using patient-reported outcome measures, compared with …

Importance Allergic rhinitis affects an estimated 15% of the US population (approximately 50
million individuals) and is associated with the presence of asthma, eczema, chronic or …

Allergic rhinitis (AR) is the most common undiagnosed chronic condition in children.
Moderate/severe AR symptoms significantly impair quality of life, and cause sleep …

In recent years a continuous increase in new cases of respiratory disorders, such as rhinitis,
asthma, and chronic obstructive pulmonary disease (COPD), has been observed. The exact …